GFM

GF Fund Management Portfolio holdings

AUM $4.97B
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
683
New
Increased
Reduced
Closed

Top Buys

1 +$43M
2 +$24.3M
3 +$16.8M
4
YUMC icon
Yum China
YUMC
+$14.4M
5
HIMS icon
Hims & Hers Health
HIMS
+$10.9M

Top Sells

1 +$40.6M
2 +$25.7M
3 +$14.3M
4
META icon
Meta Platforms (Facebook)
META
+$13.3M
5
KO icon
Coca-Cola
KO
+$9.83M

Sector Composition

1 Technology 42.51%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRGX
626
DELISTED
CARGO Therapeutics
CRGX
$4.65K ﹤0.01%
1,142
+176
ACIU icon
627
AC Immune
ACIU
$297M
$4.59K ﹤0.01%
2,454
+377
VYGR icon
628
Voyager Therapeutics
VYGR
$281M
$4.58K ﹤0.01%
1,355
+208
TVGN icon
629
Tevogen Bio Holdings
TVGN
$138M
$4.54K ﹤0.01%
4,207
+531
NGNE icon
630
Neurogene
NGNE
$459M
$4.31K ﹤0.01%
368
+56
NMRA icon
631
Neumora Therapeutics
NMRA
$293M
$3.88K ﹤0.01%
3,883
+491
THRD
632
DELISTED
Third Harmonic Bio
THRD
$3.88K ﹤0.01%
1,118
+172
FDMT icon
633
4D Molecular Therapeutics
FDMT
$526M
$3.71K ﹤0.01%
1,147
+176
SLDB icon
634
Solid Biosciences
SLDB
$479M
$3.67K ﹤0.01%
991
+152
TNGX icon
635
Tango Therapeutics
TNGX
$1.02B
$3.65K ﹤0.01%
2,665
+410
CMPS
636
Compass Pathways
CMPS
$648M
$3.61K ﹤0.01%
1,261
+193
LRMR icon
637
Larimar Therapeutics
LRMR
$372M
$3.4K ﹤0.01%
1,583
+243
SLN
638
Silence Therapeutics
SLN
$340M
$3.29K ﹤0.01%
1,165
+178
SCPH
639
DELISTED
scPharmaceuticals
SCPH
$3.27K ﹤0.01%
1,242
+191
NKTX icon
640
Nkarta
NKTX
$173M
$3.22K ﹤0.01%
1,751
+269
ALEC icon
641
Alector
ALEC
$335M
$2.99K ﹤0.01%
2,429
+284
ENTA icon
642
Enanta Pharmaceuticals
ENTA
$321M
$2.9K ﹤0.01%
525
+80
LXEO icon
643
Lexeo Therapeutics
LXEO
$498M
$2.85K ﹤0.01%
820
+126
CCCC icon
644
C4 Therapeutics
CCCC
$236M
$2.8K ﹤0.01%
1,751
+269
EDIT icon
645
Editas Medicine
EDIT
$372M
$2.45K ﹤0.01%
2,113
+283
FATE icon
646
Fate Therapeutics
FATE
$178M
$2.16K ﹤0.01%
2,737
+346
KYTX icon
647
Kyverna Therapeutics
KYTX
$324M
$2.06K ﹤0.01%
1,070
+164
PLRX icon
648
Pliant Therapeutics
PLRX
$101M
$2.04K ﹤0.01%
1,509
+231
MGNX icon
649
MacroGenics
MGNX
$108M
$1.98K ﹤0.01%
1,557
+239
CLYM
650
Climb Bio
CLYM
$157M
$1.97K ﹤0.01%
1,616
+204